Europe — EMA
Olmesartán/Hidroclorotiazida Alter (Olmesartan Medoxomil, Hydrochlorothiazide)
Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Alter, is an angiotensin II receptor blocker presented as a tablet for oral use.
Request sourcing
What is Olmesartan Medoxomil, Hydrochlorothiazide?
Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Alter, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is indicated for adults. GNH USA supplies Olmesartán/Hidroclorotiazida Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Olmesartán/Hidroclorotiazida Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olmesartan Medoxomil, Hydrochlorothiazide used for?
Olmesartan/hydrochlorothiazide is used for managing high blood pressure through combined angiotensin receptor blockade and diuretic action.
- Hypertension: improves blood pressure control when monotherapy is insufficient. - Heart failure prevention: reduces risk of cardiovascular events in patients with hypertension. - Chronic kidney disease: aids in blood pressure management to slow disease progression. - Diabetes‑related hypertension: assists in achieving target blood pressures in diabetic patients. - Stroke risk reduction: contributes to lowering the likelihood of stroke in hypertensive individuals.
What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?
Common Side Effects: - Dizziness - Headache - Fatigue - Increased urination - Electrolyte imbalance (low potassium) - Mild gastrointestinal discomfort
Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Liver function abnormalities - Blood cell disorders (e.g., agranulocytosis)
What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?
Olmesartan/hydrochlorothiazide should be used with caution in patients with renal impairment, electrolyte disturbances, and hepatic dysfunction.
- Renal function monitoring: check serum creatinine and eGFR regularly. - Electrolyte assessment: monitor potassium and sodium levels. - Hepatic health: avoid use in severe liver disease. - Pregnancy: contraindicated in the second and - Breastfeeding: discontinue - Drug interactions: review - Store at ambient: keep
What does Olmesartan Medoxomil, Hydrochlorothiazide interact with?
The
g t t """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""
Product details
Related products

Alteisduo
Olmesartan Medoxomil, Hydrochlorothiazide

Atolme Plus
Olmesartan Medoxomil, Hydrochlorothiazide

Belsar Plus
Olmesartan Medoxomil, Hydrochlorothiazide

Belsar Plus
Olmesartan Medoxomil, Hydrochlorothiazide